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1 
Abstract— Currently, some medical devices such as the 
Wireless Capsule Endoscopy (WCE) are used for data 
transmission from inside to outside the body. Nevertheless, for 
certain applications such as WCE, the data rates offered by 
current medical frequency bands can result insufficient. Ultra 
Wideband (UWB) frequency band has become an interesting 
solution for this. However, to date, there is not a formal channel 
path loss model for the UWB frequency band in the 
gastrointestinal (GI) scenario due to the huge differences between 
the proposed studies. There are three main methodologies to 
characterize the propagation channel, software simulations and 
experimental measurements either in phantom or in in vivo 
animals. Previous works do not compare all the methodologies or 
present some disagreements with the literature. In this paper, a 
dedicated study of the path loss using the three methodologies 
aforementioned (simulations, phantoms and in vivo 
measurements) and a comparison with previous researches in the 
literature is performed. Moreover, numerical values for a path 
loss model which agrees with the three methodologies and the 
literature are proposed. This paper aims at being the starting 
point for a formal path loss model in the UWB frequency band 
for WBANs in the GI scenario.  
 
Index Terms— UWB, WBAN, in-body, Wireless Capsule 
Endoscopy, Propagation Channel, Path Loss, Gastrointestinal, in 
vivo, phantoms.  
I. INTRODUCTION 
Wireless Capsule Endoscopy (WCE) has become a good 
alternative for conventional endoscopy, allowing the detection 
of diseases in some regions like the small bowel or colon, with 
the recording and transmission of images. Nevertheless, the 
current low data rate transmission in the WCE only allows the 
transmission of low quality images [1]. Higher data rates 
would allow the streaming transmission of high quality images 
or videos, which are a necessity to ease the recognition of 
diseases and enable the localization and tracking of the 
capsule [2]. 
Currently, the standard IEEE 802.15.6-2012 [3] is used for 
the regulation of wireless medical devices in Wireless Body 
Area Networks (WBANs). The standard considers the 
narrowband Medical Implant Communications Service 
(MICS) band, from 402 – 405 MHz as the optimum for 
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implanted (in-body) to surface (on-body) communications 
(IB2OB). This frequency band has good propagation behavior 
and achieves a small size for the antennas. Moreover, another 
narrowband band defined in the IEEE 802.15.6-2012 standard 
from 2.4 to 2.4835 GHz (included in the ISM band from 2.4 – 
2.5 GHz) is proposed for on-body to on-body (OB2OB) and 
on-body to external (OB2OFF) communications1.2 
Ultra Wideband (UWB) frequency band, covering from 3.1 
to 10.6 GHz, is also defined in the IEEE 802.15.6-2012 
standard for the communications from OB2OB or OB2OFF. 
This band is characterized for a very low power consumption, 
smaller size of the antennas and higher data rate [4].  
Even though those are the defined frequencies for the 
different scenarios, many works have studied the optimum 
frequency bands for IB2OB communications[5]–[7]. Some 
results consider the optimum bands to be below or around 1 
GHz. However, these results do not take into account some of 
the current necessities for the medical technology. As 
mentioned before, the low power transmission or the data rate 
that for some applications e.g., the WCE, needs to be higher 
Therefore, as described in the IEEE standard, the maximum 
data rates for MICS and ISM frequency bands are 455 kbps 
and 971 kbps respectively, whereas for UWB frequency band 
12.636 Mbps are defined [3]. Moreover, the smaller size of the 
antennas, as well as the power consumption, are some 
desirable characteristics for the future ingestible devices. 
For these reasons, recent investigations [8]–[10], are 
considering the UWB frequency band as a possible candidate 
to substitute the MICS band for high data rate communications 
for implanted devices in WBANs. UWB frequency band is 
also characterized by the high attenuation suffered by the 
transmitted signal when it propagates across the human 
tissues. Furthermore, such attenuation is frequency-dependent 
due to the variation with frequency of the electromagnetic 
properties of the human body tissues [11], [12]. Thus, a proper 
channel characterization is a key factor to consider the UWB 
frequency band as the future of WBANs.  
The three main methods to characterize the propagation 
channel in the WBANs are through numerical software-based 
simulations [13], [14], and experimental measurements either 
in laboratory environment with phantoms [15], [16] or through 
in vivo experiments [17]–[20]. Each method has different 
strengths and weaknesses: Software-based simulations are 
easy to perform, and they are available for everybody through 
commercial software e.g., CST® MWS®, ANSYS® HFSS. 
Nevertheless, the high complexity of the simulations, the high 
computational time and the unreal conditions of the 
simulations drive to the conclusion that this methodology 
itself is not enough to properly characterize a WBAN channel. 
 
1 The mentioned standard defines more narrow frequency bands than the 
MICS and ISM. Nevertheless, those are the most widely used among the 
scientific community and manufacturers 
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2 
In vivo experiments are performed in hospitals or laboratories 
with facilities adapted for these experimental purposes. These 
measurements are the most similar to a real case because they 
take into account all the tissues, blood and internal movements 
among other factors that appear in the living bodies. On the 
contrary, since the animal is alive, a proper location of the 
antenna and the control of the environment is a challenging 
work. Moreover, there are many ethical restrictions regarding 
the experimentation with living animals [21]. Lastly, the so-
called phantom measurements are becoming a good  
alternative to in vivo experimentation, reducing the animal 
experimentation. In general, phantoms are created to emulate 
certain characteristics of the human body [22], [23], e.g., 
color, texture, size, weight. For the case of propagation in 
WBANs, the electromagnetic (EM) properties of the human 
tissues [15], [24], [25] – reported in [26] – are the desired 
parameters to mimic. Unfortunately, phantoms in the UWB 
frequency band are not easy to achieve and plenty of 
researches are performed using phantoms that were not 
accurate enough [15], [18]. However, in [27]–[29], authors 
used novel accurate phantoms that properly mimic the human 
tissues in the spectrum from 0.5 to 26.5 GHz [25], [30], and 
are protected by patent [31]. In addition, the measurement 
setup should be designed for the IB2OB scenario in order to 
avoid some inaccuracies such as the bad isolation of the 
measurement environment. Thus, in [32] phantom 
measurements were performed with accurate phantoms and a 
testbed specifically designed for the purpose of IB2OB 
scenario in the WBANs. 
In addition, in the GI scenario, some existing works are 
only focused in one methodology or sometimes two of them, 
such as in [18], [29], where a comparison between in vivo 
experiments and phantoms are performed. Therefore, to the 
best of the authors’ knowledge, there are no studies in the 
literature reporting a comparative study between the results 
obtained from the three methodologies in the GI scenario. 
Moreover, the current literature regarding channel 
characterization is not homogeneous, i.e., different frequency 
bands, distance range and antennas are considered for each 
study. Thence, there is a lack of a unified PL model for the GI 
part of the human body. 
In this paper, a comparative study between the three 
methodologies aforementioned (software simulations, in vivo 
and experimental measurements with phantoms) is presented. 
Moreover, the three setups considered for the three 
methodologies are intended to mimic the real applications of 
the IB2OB GI scenario. Like the WCE, where the transmitting 
antenna is located inside the intestine of the human body and 
the receiving antenna is placed over the abdominal region of 
the human body. Moreover, simulations and experiments are 
designed to be as similar between them as possible. The 
research performed in [32], with heterogeneous accurate 
phantom is extended here and results are compared with 
realistic in vivo experiments. As a result, path loss (PL) 
models considering the three methodologies are given and 
compared. Finally, a comparative study of different PL models 
already presented in the literature is discussed.  
The reminder of this paper is as follows: in section II the 
methodology used for each measurements type is described, 
section III presents the results obtained for all the 
methodologies and the path loss model values. Section IV 
presents the discussion with previous literature. Lastly, the 
conclusion of this paper is given in section V. 
II. MEASUREMENT AND METHODOLOGY 
A. Scenario of interest 
In IB2OB scenario, the antennas used for the 
communications are highly affected by the human tissues 
surrounding them. Thus, antennas should be designed for 
this particular scenario, either implanted transmitting 
antenna [23], [33] or on-body receiving antenna [34], [35]. 
In Fig.  1, the antennas used for this work are shown. 
Concretely, the on-body antenna is a quasi-omnidirectional 
antenna in the UWB frequency band for on-body 
communications with 5 cm and 4.4 cm length and width 
respectively [36]. The in-body antenna has a smaller size, 
2.3 cm × 2 cm, also with a quasi-omnidirectional radiation 
pattern in the UWB frequency band. Such antenna has been 
designed and miniaturized taking into account the 
surrounding body tissues as detailed in [28].  
 
 
B. Phantom measurements 
In the gastrointestinal scenario, the main tissues involved in 
the signal transmission are: large or small bowel, muscle, fat, 
skin and blood. In  Fig.  2(a) and (b) the dielectric constant 
and conductivity given by [26] for such tissues are plotted.  
As one can observe, muscle, colon and small bowel have 
similar dielectric constant and conductivity in the low UWB 
frequency band. Considering this issue and for the sake of 
simplicity these three tissues will be considered as only one. 
Hereinafter, muscle phantom tissue will be employed for 
simulations and phantoms measurements. However, for in vivo 
experiments since the proper placement of the in-body antenna 
is an arduous task, the location either in colon or small bowel 
is considered indistinctly  
In Fig.  3, the setup used for the phantom measurements is 
shown. The setup consists of a small anechoic chamber 
designed for frequencies above 1.3 GHz (Fig.  3, element. 1). 
Inside the anechoic chamber, a magnetic tracker (Fig.  3, 
element 4a), a 3D Cartesian positioner (Fig.  3, element 2a), a 
multilayer phantom container (Fig.  3, element 5), and the 







Fig.  1. On-body and in-body antenna [28].  




The multilayer phantom container consists of a squared 
container with two layers of 23 cm × 25 cm × 25 cm and 2 cm 
× 25 cm × 25 cm, filled with muscle phantom [30] and fat 
phantom [25], [37] respectively. The dielectric constant and 
the conductivity of both phantoms are depicted in [32] they 
show a high level of agreement compared with the literature. 
Concretely, a deviation of less than 1% for both parameters is 
achieved for the muscle phantom, whereas 4% and 12% of 
deviation are reached for the dielectric constant and 
conductivity of the fat phantom. 
 
 
The 3D Cartesian positioner precisely places the 
transmitting antenna inside the phantom container (264 
positions), concretely inside the muscle layer. The receiver is 
located over the external wall of the fat layer. The receiver 
position is shifted over the fat layer wall to mimic the multi-
receiver case. Finally, the 3D magnetic tracker (Ascension 
Technology Corporation, trakStar with a Mid-Range 
Transmitter) creates a magnetic field thanks to a magnetic 
transmitter located inside the anechoic chamber. Two 
magnetic sensors are attached to both antennas, giving the 
exact distance between antennas.  
Table I column 1 summarizes the configuration parameters 
of the VNA for the phantom measurements. A detailed 
explanation of this measurement setup, as well as further 
details, can be found in [32].  
 
C. In vivo measurements 
The in vivo experiment was performed in a living porcine 
model in the facilities of the Hospital Universitari i Politècnic 
la Fe, Valencia, Spain. Pigs and humans have similar GI 
conditions, either in size and distribution of the organs, thus 
these animals are commonly used for digestive 
experimentation. This experiment was conducted for digestive 
surgeons and the method used to perform the surgery in the 
animal was a laparoscopy. Moreover, the in vivo 
measurements were designed to be as similar as possible to the 
phantom measurements aforementioned. 
Fig.  4 shows the laparoscopy performed in the abdominal 
cavity of the pig. As seen, four incisions were performed: Fig.  
4 element 1 to insert the in-body antenna and the cable; Fig.  
4, element 2 to insert the gas (CO2) used to inflate the 
abdominal cavity of the pig and Fig.  4, elements 3a and 3b to 
insert the laparoscope itself and the laparoscopic instruments, 




Again, measurements were based on a Vector Network 
Analyzer (VNA), where the in-body and on-body antennas 
(Fig.  1) are connected to the port 1 and 2 of the VNA through 
coaxial cables. In addition, the same 3D magnetic tracker as in 
phantom measurements with two sensors attached to both 
antennas was used in the surgical procedure. In Table I second 
column the configuration parameters of the VNA for the in 
vivo measurements are given. 
 From measurements, the forward transmission coefficient 
(S21) for different IB2OB positions was calculated. Besides, 5  
TABLE I.  
VNA PARAMETERS  
 Phantom measurements In vivo measurements 
Resolution points N = 3201 N =1601 
Frequency band f = [3.1, 8.5] GHz f = [3.1, 6] GHz 
IF Bandwidth fif  = 3 kHz fif  = 3 kHz 
Output Power P = 8 dBm P = 8 dBm 
 
 
Fig.  2. (a) Dielectric constant and (b) Conductivity of the human 




















































Fig.  4. In vivo Measurement setup. Detailed view. 
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snapshots of the S21 are taken per each IB2OB position and 
then the average value of such coefficient is calculated. The 
magnetic tracker also computes 100 positions per each IB2OB 
position, which are also averaged. In addition, the dynamic 
range for this configuration was found to be 100 dB.  
In Fig.  4, a general view of the receiver grid over the pig is 
shown.  The grid of the positions of the on-body antenna used 
over the abdomen of the pig is detailed in Fig.  5. 
 
 
Such on-body grid consists of 13 receiving positions (Rxs). 
They are placed considering the real case where different 
receivers are located in different positions over the abdomen. 
It should be mentioned, that the CO2 used for the laparoscopy 
is removed once the transmitting antenna is placed in the 
desired position. Therefore, the measurements are done 
without any gas, closer to the real case.  
Regarding the in-body antenna, 3 different in-body 
positions, were considered. Since the scenario of interest is 
mainly the GI tract of the animal, the in-body positions were 
located to be surrounded by either colon or small bowel 
indistinctly. Fig.  6 shows the pictures of the in-body positions 
taken during the surgical procedure. Tx1 and Tx3 (Fig.  6(a) 
and (c) respectively) are surrounded by small bowel, whereas 
Tx2 (Fig.  6(b)) is surrounded by small bowel and colon. 
D. Simulations 
Software simulations were performed with the commercial 
software CST® MWS®, hereinafter CST. For these 
simulations, the Time Domain (TD, transient) solver was 
chosen. Concretely, this software uses the Finite Integration 
Technique (FIT) as a numerical method to calculate the 
electromagnetic fields of a certain setup and, in our case, the 
S-parameters. Simulations were undertaken to confirm the 
values deduced from phantom and in vivo measurements. With 
this aim, two different configurations were considered: 
A) The experimental testbed of Fig.  3 is replicated in 
CST. More information about this simulation design 
can be found in [32].  
B)  The abdominal part of a human female CAD model 
(Nelly) was chosen to confirm whether the 
measurements in a living pig were well performed. It 
should be mentioned that to reduce the complexity of 
the simulation, only the skin, fat and muscle of the 
human body was considered, as shown in Fig.  7. 
Besides, in order to have the most accurate result, cells 
with a mesh size ranging from an edge length of 0.14 to 
2.61 mm were used for these simulations. 
 
 
In case B simulations, the in-body and on-body antennas 
were located in different positions along X, Y, and Z axes. 
Fig.  7 depicts these different positions. The on-body antenna 
is placed in 3 different positions over the skin layer of the 
CAD model Nelly. For the in-body antenna, 6 in-body 
positions were considered as shown in Fig.  7. Thus, a total 
range of distances between in-body and on-body antennas 
ranging from d = 4 cm to 7.95 cm is achieved. 
III. RESULTS 
A. Antenna Matching 
As mentioned before, the antenna matching varies with the 
surrounding tissues. Therefore, the reflection coefficient (S11) 
of either in-body and on-body can vary depending on its 
location, especially in real configuration. In Fig.  8, the 
absolute value of the S11 is shown for in vivo measurements 
considering the three transmitting positions (Tx1, Tx2, Tx3) 









































Fig.  7. CST Human CAD model, Nelly and the in-body and on- 
body grid used. 
 
    
 (a)  (b)                (c) 
Fig.  6. In-body positions (a) In-body position 1 (Tx1), (b) In-body position 2 (Tx2), (c) In-body positions 3 (Tx3). 
 




As can be observed, the reflection coefficient of the in-body 
and on-body antenna varies depending on the position of the 
antenna, i.e., Tx1 and Tx3 show similar response (both are 
surrounded with small bowel), while Tx2 has slightly different 
shape. In any case, the S11 has a maximum value of -7 dB for 
Tx1, for which, we consider this antenna matched as well as in 
[20], where the antenna is considered matched for a value 
below -6 dB for in vivo experiments.  
The on-body matching is also shown, with the reflection 
coefficient plotted for 3 different on-body positions. As seen, 
the on-body reflection coefficient is always below -10 dB. 
Moreover, in [32], the reflection coefficient for the in-body 
and on-body antenna are plotted, showing a high level of 
agreement either in the shape and values of the curve with 
those represented in Fig.  8. 
B. Channel transfer function 
The N-points channel transfer function in frequency domain 
can be deduced from measurements as 2121( )
SjH f S e
−
=  
being 21S  and 21S  the module and the phase of the forward 
transmission coefficient (S21) given by the VNA and f the 
frequency. In Fig.  9,  the channel transfer function is depicted 
for different in-body and on-body positions from 3.1 to 6 
GHz.  
One can observe how as the distance between antennas 
becomes larger, the response of the channel transfer function 
above the noise floor (-90 dB in terms of relative received 
power) decreases, and thus, the useful bandwidth. So, from 
Fig.  9, distances above d = 7.62 cm and frequencies above f = 
5.1 GHz, the signal is considered to be under the noise floor 
level. Therefore, for further analysis, a trade-off between the 
maximum distance between antennas and the maximum useful 
bandwidth should be achieved. Hereinafter, the frequency 
band considered is 3.1-5.1 GHz and the larger distance is d = 8 
cm. These results agree with the literature in which the low 
UWB frequency band is studied [17], [38]. 
 
 
In addition, the simulations with the CST CAD model Nelly 
(case B) were also performed and compared with the channel 
transfer function in in vivo measurements (Fig.  10). It should 
be mentioned that simulations were performed only for the 
desired frequency band, i.e., 3.1 to 5.1 GHz in order to reduce 
the computational cost.  
Fig.  10 also shows that the slope of the channel transfer 
function is very similar for similar distances between 
antennas. It is important to take into account that inside the 
pig, the exact tissues between antennas are unknown. 
 
In this comparison, it is possible to see the high similarities 
between the results performed with both methodologies as 
well as in [32], where the phantoms measurements were 
compared with software simulations (Case A). In that case, 
when the antennas were completely aligned and perfectly 
matched with the simulations, the results were very similar. 
Same occurs here, where the comparison between in vivo and 
simulations (Case B) shows a high level of matching, 
validating the in vivo measurements 
C. Path Loss  
The path loss (PL) is obtained from the channel transfer 
function as: 
 
Fig.  8. Reflection coefficient parameters for different in-body and 




Fig.  9. Channel transfer function for in vivo values. 
 
 
Fig.  10. Comparison of H(f) for in vivo (solid) measurements and 
software simulations (Case B) (dashed).  
 





















   (1) 
Fig.  11 illustrates the path loss as a function of the distance 
for the in vivo and numerical simulations with Nelly (Case B). 
In this work, the antenna behavior is considered, being thus, a 
radio link budget evaluation. However, in literature the term 
path loss is commonly used. 
 
One can observe how the PL values given by the numerical 
simulations are few decibels below those deduced from the in 
vivo measurements. This slightly mismatch is given for all the 
contributions that appear in real experiments, i.e., reflections 
inside the pig, blow flow, respiration etc., which are not 
considered in the numerical simulations. Moreover, in 
simulations, both antennas are faced, whereas in in vivo 
measurements a perfect alignment between antennas is 
difficult to achieve. Same occurs in [32], where the values of 
the numerical simulations (case A) are lower than 
experimental measurements in phantom. 
In order to obtain a general path loss model, phantom 
measurements have to be taken into account for the large 
number of positions obtained and the real external conditions 
of the measurements. For this purpose, Fig.  12 represents the 
path loss values obtained from multilayer phantom 
measurements in [32], together with the in vivo measurements 
and software simulations (Case B)  
From Fig.  12 a similar trend and path loss values between 
the three configurations can be observed. Nevertheless, the 
data values obtained from the multilayer phantom container 
have a shift of two centimeters in the X axis. It should be 
highlighted that the experiments performed in phantom 
measurements considered muscle and a 2 cm width of fat 
phantom layer. As depicted in Fig.  2, the conductivity of the 
fat is very low, barely affecting the attenuation of the signal. 
As a consequence, the distance used for this model can be 
changed regarding the quantity of abdominal fat. To confirm 
this, a new phantom measurement campaign was performed 
using only homogeneous muscle phantom and using the same 
frequency band (3.1 to 5.1 GHz) and the same antennas. 
 
Fig.  13(a) shows the comparison between the multilayer 
and the homogenous phantom-container measurements. As 
seen, in  Fig.  13(b), where the multilayer measurements are 2 
cm shifted for the distance from 3 to 6 cm approximately, the 
PL values between both measurements are very similar. The 
multilayer has about an average PL data value of 2 to 3 dBs 
above the homogenous PL, which is due to the extra losses 
introduced by the fat.  
 
Therefore, from the results obtained with this comparative, 
the measurements performed with fat phantom, can be shifted 
up to 2 cm to the left (Fig.  13(b)) in order to replicate as much 
as possible the in vivo results, where the pig has less than 2 cm 
of abdominal fat. In addition, in Fig.  13(a)) the results from 
simulations (case A) are shown. These data values correspond 
to the software design mimicking the experimental phantom 
measurements. As seen, phantom measurements and software 
simulations show a high level of agreement, being the 
simulation values in the lower part of data cloud in phantom. 
As discussed in [32] this is for the perfect alignment and 
perfect conditions considered in simulations, which are not 
always easy to achieve in real measurements.  
 Finally, in Fig.  14, the comparison between the in vivo 
measurements, shifted phantom measurements and software 
simulations (Nelly model, case B) are shown. In this case, the 
 
Fig.  11. Path loss model values for the in vivo and numerical 
simulations (Case B) 
 
 




Fig.  13. Homogeneous vs heterogeneous path loss models. (a) 
Original PL data values and CST phantom design simulations (case 
A) (b) Multilayer PL data values 2 cm shifted 
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agreement between results coming from the three 
methodologies is clearly shown. Therefore, a more general PL 
model can be deduced from the results.  
 
D. Path Loss Models 
The most accurate fitting model should be determined in 
order to achieve the best fitting to the samples. Although the 
most common path loss model is the logarithmic one [39], 
some other works in literature have proposed a linear fitting 
[17]. Equations (2) and (3) describe the logarithmic and linear 
PL models. The logarithmic PL model is given by: 
 10 0
0
( ) 10 log ( ) (
d




= + +   ) 
 
  (2) 
being d the separation between antennas, d0 the reference 
distance, PL0(dB) the reference PL value at the reference 
distance (d0), γ the logarithmic path loss exponent and X(,µ) 
the statistical distribution modeling the shadowing term of the 
signal. Such statistical distribution typically follows a 
Gaussian model with mean, µ, and standard deviation of .  In 
the same manner, the linear model is given by: 
 0
0
( ) ( ) (
d




= + +   ) 
 
  (3) 
where, α is the slope of the line. It should be mentioned that 
the maximum distance achieved for simulations, phantom 
measurements and in vivo measurements is not exactly the 
same. In the case of the in vivo experiments the maximum 
distance measured is dmax = 8.067 cm. For the multilayer 
phantom model is dmax = 9.5 cm or dmax = 7.5 cm (if the 
samples are shifted 2 cm due to the fat layer). In software-
based simulations, the maximum distance d = 7.95 cm. Results 
are shown in Table II where the Root Mean Squared Estimator 
(RMSE) is computed for both the linear and logarithmic 
method, for the three methodologies. Measured path loss 
models and fitting models are plotted in Fig.  15.  
From the Table II, the results with logarithmic and linear 
model seem to be unalike. Nevertheless, for all the models the 
RMSE have similar values. In Fig.  15 it is possible to visually 
realize the similarities between models for the range of given 
distances. 
 
Regarding the comparison between methodologies. The 
shifted phantom model and the simulations (Case B) are very 
similar, as shown for the α and γ values. The in vivo 
measurements show slightly different results, as expected 
from the data values. Nevertheless, all the three trends are 
very similar.  
 Therefore, from the given distance range (3 to 8 cm) and the 
given frequency band (3.1 to 5.1 GHz), we can assume that 
the exponential factor either in the logarithmic or linear model 
varies from γ = 5.4 to 8.9 and α = 4.3 to 6.8 and the standard 
deviation of the scattering  = 2 to 4.6 dB, for both models. 
TABLE II. 
 PATH LOSS MODELS 
 Logarithmic Linear 
In vivo PL0=26.2266 dB 
d0 = 1 cm 
γ  = 5.3967 
µ  0 
 = 4.4972  
RMSE = 28.1 
PL0= 41.5635 dB 
d0 = 1 cm 
α = 4.337 
µ  0 
 = 4.6007 





PL0 =-8.3767 dB 
d0 = 1 cm 
γ  = 8.9681 
µ  0 
 =1.9795 
RMSE = 7.5 
PL0= 19.7445 dB 
d0 = 1 cm 
α = 6.8262 
µ  0 
 = 1.9489 
RMSE = 7.37 
Phantom PL0 =-29.7593 dB 
d0 = 1 cm 
γ  = 10.3395 
µ  0 
 = 2.3069 
RMSE = 3.64 
PL0 = 13.8201 dB 
d0 = 1 cm 
α = 6.1719 
µ  0 
 = 2.2724 
RMSE = 3.54 
Phantom 
shifted 
PL0 = 6.29 dB 
d0 = 1 cm 
γ  = 7.3824 
µ  0 
 = 2.3772 
RMSE = 3.88 
PL0 = 26.1639 dB 
d0 = 1 cm 
α = 6.1719 
µ  0 
 = 2.2724 
RMSE = 3.51 
 
 




Fig.  15. Path Loss measured and simulated data along with their 
fitted linear and logarithmic models 




In this section, the similarities with other PL models already 
presented in literature are discussed. As already mentioned, 
the PL is highly affected by the location of the antenna in the 
human body due to the different EM properties of the human 
tissues, as well as by the antenna characteristics, which cannot 
be de-embedded from measurements. Therefore, only PL 
models for the abdominal region or muscle tissue will be taken 
into account, regardless of the antennas used.  
In [11] a first approach of comparison was studied. 
However, a comparison between some path loss models 
regardless of the model and the methodology used is 
performed. From this work, we have chosen the PL models 
with similar characteristics as the described here, i.e., same 
distance, frequency, scenario and mathematical model 
(logarithmic or linear) to evaluate the discrepancies or 
similarities between the already presented and our models. For 
our case of study, the logarithmic models for simulations, in 
vivo and phantoms are chosen to standardize with the 
literature, since mostly all the models are logarithmic. 
Fig.  16 shows the PL models within a distance range from 
3 to 8 cm and a frequency range between 3.1 to 5.1 GHz and 
considering abdominal or gastrointestinal scenario. It should 
be mentioned that some models have an initial distance value 
above 3 cm. In these cases, the PL model is only represented 
for their defined distance range. 
In Fig.  16(a), the PL models as a result of software 
simulations are studied. Concretely, in [38], (Y. Shimizu et 
al.), some simulations are performed in the abdominal region 
for a frequency band from 3.4 to 4.8 GHz and defined from a 
distance range from 5 to 9 cm. This model and ours (dotted 
line) have a high level of agreement, with similar increasing 
trend. In [40] (Shi et al.) simulations are also performed from 
the same frequency band as Shimizu but for a distance range 
from 2 to 24 cm. For this study, 3 curves are depicted because 
the authors proposed 3 different PL models regarding the 
position of the receivers. One can observe an evident 
difference between models. Our model and the models defined 
by Shi have a quite different slope. This is due to the large 
distance range (22 cm) defined at [40]. In Fig.  16(b), the 
experimental PL models obtained either for phantom 
measurements or in vivo measurements are depicted. In [27] 
(Andreu et al), homogeneous phantoms measurements are 
performed. The frequency band starts at 3.1 to 8.5 GHz and 
the distance range vary from 5.5 to 20 cm. In [17] (Garcia-
Pardo et al) homogeneous phantom and in vivo measurements 
are compared. In this case, the selected frequencies vary from 
3.1 to 5 GHz, the distance range from 5 to 11 cm. In addition, 
it is the only linear model presented. Finally, two other 
experimental models presented by Shimizu et al in [19] are 
depicted. Again, the frequency band selected is from 3.4 to 4.8 
GHz and the distance range from 3 to 12 cm. Two models are 
presented because they performed measurements with one 
antenna but two different polarization. In Fig.  16(b), it is 
possible to see how the in vivo model presented by Garcia-
Pardo and our proposed phantom model, have a high level of 
agreement although the in-body antennas used were not the 
same. Moreover, our proposed in vivo model shows a quasi-
perfect matching with the presented model by Shimizu 2 (also 
deduced from in vivo measurements and with different 
antennas). Moreover, the logarithmic exponent given by 
Shimizu 2 (in vivo) and Garcia-Pardo (in vivo) γShimizu = 5.2 
(logarithmic) and αGarcia-Pardo = 5.2 (linear), match with our 
given values in the previous section. 
 In addition, it should be remarked that the models proposed 
by Andreu [27] and Shi in [40] are given for larger distance 
ranges than the other models: 14.5 and 22 cm respectively. 
And both of them present a large disagreement with other 
models presented in literature. 
 
V. CONCLUSIONS 
In this paper, the radio channel in a gastrointestinal scenario 
in the lower part of the UWB frequency band (3.1-5.1 GHz) is 
studied. Some novelties are presented in this paper. Firstly, the 
path loss models are computed using three different 
methodologies for the channel characterization, i.e., software 
simulations, experimental measurements in multilayer 
phantom and in vivo realistic experiments. Then, for each 
methodology linear and logarithmic path loss models were 
evaluated. As a result, it was shown that the measured path 
loss data values obtained from the three methodologies have a 
high level of agreement between them in terms of losses as a 
function of distance. In addition, it was found that the width of 
fat present in the body affects the model since the distance 
between antennas increases while not the losses.  
Comparing our results with others already proposed in the 
literature in the gastrointestinal scenario, and in the same 
frequency band (3.1-5.1 GHz) some interesting conclusions 
were obtained: in simulations, phantoms and in vivo 
measurements the closest models were those with similar 
conditions while the antennas used seem not to have a decisive 
 
Fig.  16. Comparison between proposed and presented models 
found in literature (a) Simulations (b) Experimental measurements 
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impact in the results. However, those with the same antennas 
but larger distance range or different frequency band showed 
higher disagreement 
For all of this, we can conclude that for the gastrointestinal 
scenario, for a distance range from 3 to 8 cm and a frequency 
band of 3.1 to 5.1 GHz the path loss exponent is in between 
4.3 to 6.8 and 5.4 to 8.9 for linear and logarithmic models 
respectively. It should be highlighted that such results were 
supported by in vivo measurements in a very realistic case 
where three different positions of the small bowel and colon 
were considered.  
In-body communications in UWB frequency band are still 
an open topic for future research. First, the improvement of 
phantom measurement setups to make them more similar to a 
real in vivo scenario is an open issue. In addition, more in vivo 
values are needed to obtain more data values, which lead to 
more accurate PL models. Furthermore, more measurements 
using different kinds of antennas are necessary to confirm 
these findings and generalize them. Because, as deduced from 
the results in section IV not only the antennas but other 
variables such as the tissues or the frequency range impact on 
the channel characteristics. For the best of our knowledge, 
there are no works focused on the channel characterization 
using different in-body antennas and considering different 
methodologies of analysis (software, phantom measurements 
and in vivo measurements). Finally, a deeper study about how 
the frequency could influence the received signal in the UWB 
frequency band is needed. 
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